Sorin Group Acquires Gish Biomedical

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced Tuesday that it has acquired Gish Biomedical from Ventizz Capital Partners, a private equity group focused on technology-oriented companies.
Forbes